08/24/2026
Three FDA-approved medications for alcohol use disorder, and they're not interchangeable.
One reduces heavy drinking days and can work when the patient isn't aiming for abstinence.
One is renally cleared, which matters with liver disease. One is aversive, not anti-craving, and performs under conditions most patients can't meet. There are also other evidence-supported options used off-label.
Matching the medication to the patient's goal, comorbidities, and adherence pattern is a skill which may not have been emphasized in training.
CSAM membership supports that continued learning through education, clinical resources, and connection with colleagues facing the same treatment decisions.
Join at https://bit.ly/4bSNTQf